Login or Sign Up
16:01 Dec 05
Beryl Drugs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Beryl Drugs Ltd. Financials
Beryl Drugs Ltd.
Industry Pharmaceuticals
16:01 Dec 05
Quality
0/100
Not Eligible
Valuation
53/100
Affordable Valuation
Technical
49/100
Technically Neutral
Strength
5
Weakness
7
Opportunity
0
Threats
0
6.09 %
ROE %
0.00 %
ROA %
0.00
EPS
0.00
BVPS
6.21 %
Net Profit Margin
| Mar 2017 | Mar 2018 | ||
|---|---|---|---|
| Net Sales | 11.53 | 15.99 | |
| Operating Expenses + | 11.31 | 14.3 | |
| Raw Material | 6.94 | 8.91 | |
| Increase Decrease in Cost | -0.45 | 0.45 | |
| Other Manufacturing Expense | 0 | 0 | |
| Employee Cost | 0.98 | 0.73 | |
| Miscellaneous Expenses | 3.84 | 4.21 | |
| Operating Profit | 0.22 | 1.69 | |
| Other Income | 0 | 0 | |
| Depreciation | 0.38 | 0.33 | |
| Interest | 0.2 | 0.13 | |
| Profit before tax and exceptio.. | -0.36 | 1.23 | |
| Exceptional Items | 0 | 0 | |
| PBT | -0.36 | 1.23 | |
| Provision for Taxation | 0.05 | 0.23 | |
| Net Profit | -0.41 | 0.99 | |
| NET Profit after MI | -0.41 | 0.99 | |
| EPS | 0 | 1.96 | |
| Operating Profit Margin (%) | 1.91 | 10.57 | |
| Net Profit Margin (%) | -3.56 | 6.19 |
Beryl Drugs Ltd. Shareholding
Promoter
FII
Public
All Data in Percentage (%)
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Promoter | 26.40 | 26.40 | 26.40 | 26.40 | 26.40 | 26.40 |
| FII | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Others | 73.60 | 73.60 | 73.60 | 73.60 | 73.60 | 73.60 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
Back
OTP sent to your mobile number. Please enter it below to verify.
Verify Email OTP
OTP sent to
Dear User, please
complete your profile!
Email ID Already Exists
Location Saved
Successfully
Email Id Verified
Successfully